Cell Source, Inc.

CLCS · OTC
Analyze with AI
12/31/2024
9/30/2024
6/30/2024
3/31/2024
Assets
Cash & Equivalents$75$23$91$0
Short-Term Investments$0$0$0$0
Receivables$50$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1$1$18$2
Total Curr. Assets$287$265$430$83
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$0$0$0$0
Other Assets$0$0$0$0
Total Assets$287$265$430$83
Liabilities
Payables$1,889$2,036$1,752$1,882
Short-Term Debt$10,068$10,097$10,007$9,322
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$100
Other Curr. Liab.$6,050$6,024$627$520
Total Curr. Liab.$19,083$19,205$17,749$16,837
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$19,083$19,205$17,749$16,837
Equity
Pref Stock$2$2$2$2
Common Stock$45$43$42$41
Retained Earnings-$46,438-$45,849-$44,432-$42,943
AOCI$0$0-$1-$1
Other Equity$0$0$1$0
Total Equity-$18,796-$18,941-$17,320-$16,754
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$287$265$430$83
Net Debt$9,993$10,074$9,917$9,322
Cell Source, Inc. (CLCS) Financial Statements & Key Stats | AlphaPilot